CG
MLTX icon

Cutler Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Cutler Group’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		$125K Buy
2,500
+1,400
+127% +$70K 0.04% 240
2023
Q4 		$66K Sell
1,100
-1,300
-54% -$78K 0.01% 599
2023
Q3 		$136K Buy
+2,400
New +$136K 0.01% 484